QR Code

Systemic Drivers and Molecular Mechanisms of Sarcopenia in Aetiology‐Specific End‐Stage Liver Disease

ABSTRACT Background Patients with end‐stage liver disease (ESLD) often present with sarcopenia, defined as loss of skeletal muscle mass and quality, which is associated with reduced quality of life and increased mortality. However, the molecular mechanisms driving sarcopenia in ESLD are not fully un...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Thomas Nicholson, Sophie L. Allen, Jonathan I. Quinlan, Amritpal Dhaliwal, Michael Macleod, Joshua Price, Jon Hazeldine, Michael S. Sagmeister, Caitlin Ditchfield, Kirsty C. McGee, Felicity R. Williams, Ahmed M. Elsharkawy, Matthew J. Armstrong, Carolyn A. Greig, Janet M. Lord, Leigh Breen, Simon W. Jones
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wiley 2026-06-01
Rangatū:Journal of Cachexia, Sarcopenia and Muscle
Ngā marau:
cytokines
end‐stage liver disease
human myotubes
sarcopenia
skeletal muscle
Urunga tuihono:https://doi.org/10.1002/jcsm.70294
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite